United States · FDA National Drug Code directory
Cladribine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42658-010_2c5c0edf-8718-40f2-e063-6294a90aacd0
- Product NDC
- 42658-010
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Cladribine
- Labeler
- Hisun Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200518
- Source listing expiry
- 20261231
Source-listed ingredients
- CLADRIBINE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 VIAL, SINGLE-DOSE (42658-010-91) · 42658-010-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →